Integrated BioPharma, Inc. Retains Financial Advisor

HILLSIDE, N.J., May 24, 2007 (PRIME NEWSWIRE) -- Integrated BioPharma, Inc. (Nasdaq:INBP) announced today that it has retained Merriman Curhan Ford & Co. (AMEX:MEM) to act as the Company's financial advisor. INBP had previously announced its intent to engage a financial advisor to assist in its review of a possible divestiture of its InB:Biotechnologies subsidiary ("Biotech"). INBP now expects that such divesture will be structured as a spin-off of Biotech, which will focus on its patented plant-based technology for the production of vaccines, antibodies and therapeutic proteins. INBP will continue to focus on its nutraceutical segment.